|
Name |
3-Amino-2,6-dimethoxypyridine
|
Molecular Formula | C7H10N2O2 | |
IUPAC Name* |
2,6-dimethoxypyridin-3-amine
|
|
SMILES |
COC1=NC(=C(C=C1)N)OC
|
|
InChI |
InChI=1S/C7H10N2O2/c1-10-6-4-3-5(8)7(9-6)11-2/h3-4H,8H2,1-2H3
|
|
InChIKey |
PTBHRJOTANEONS-UHFFFAOYSA-N
|
|
Synonyms |
3-Amino-2,6-dimethoxypyridine; 28020-37-3; 2,6-dimethoxypyridin-3-amine; 3-Pyridinamine, 2,6-dimethoxy-; 2,6-Dimethoxy-3-pyridinamine; Maybridge1_008017; SCHEMBL656848; 2,6-dimethoxypyridine-3-amine; 3-amino-2.6-dimethoxypyridine; HMS564E09; 2,6-dimethoxy-pyridin-3-ylamine; DTXSID40343903; 2,6-Dimethoxy-3-pyridinamine #; ZINC111531; MFCD00832865; AKOS009158431; CS-W005692; FS-2753; GK-0001; SB76443; 3-amino-2,6-dimethoxypyridine, AldrichCPR; DB-067864; FT-0647733; EN300-57156; 020A373; A876801; J-511528
|
|
CAS | 28020-37-3 | |
PubChem CID | 593005 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 154.17 | ALogp: | 0.8 |
HBD: | 1 | HBA: | 4 |
Rotatable Bonds: | 2 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 57.4 | Aromatic Rings: | 1 |
Heavy Atoms: | 11 | QED Weighted: | 0.692 |
Caco-2 Permeability: | -4.463 | MDCK Permeability: | 0.00002390 |
Pgp-inhibitor: | 0 | Pgp-substrate: | 0.066 |
Human Intestinal Absorption (HIA): | 0.006 | 20% Bioavailability (F20%): | 0.002 |
30% Bioavailability (F30%): | 0.004 |
Blood-Brain-Barrier Penetration (BBB): | 0.835 | Plasma Protein Binding (PPB): | 64.40% |
Volume Distribution (VD): | 0.938 | Fu: | 29.32% |
CYP1A2-inhibitor: | 0.828 | CYP1A2-substrate: | 0.799 |
CYP2C19-inhibitor: | 0.234 | CYP2C19-substrate: | 0.837 |
CYP2C9-inhibitor: | 0.064 | CYP2C9-substrate: | 0.528 |
CYP2D6-inhibitor: | 0.019 | CYP2D6-substrate: | 0.899 |
CYP3A4-inhibitor: | 0.101 | CYP3A4-substrate: | 0.323 |
Clearance (CL): | 8.512 | Half-life (T1/2): | 0.31 |
hERG Blockers: | 0.055 | Human Hepatotoxicity (H-HT): | 0.305 |
Drug-inuced Liver Injury (DILI): | 0.776 | AMES Toxicity: | 0.744 |
Rat Oral Acute Toxicity: | 0.564 | Maximum Recommended Daily Dose: | 0.028 |
Skin Sensitization: | 0.218 | Carcinogencity: | 0.256 |
Eye Corrosion: | 0.014 | Eye Irritation: | 0.888 |
Respiratory Toxicity: | 0.849 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC000501 | 0.333 | D09GYT | 0.296 | ||||
ENC000168 | 0.333 | D07PAO | 0.294 | ||||
ENC000712 | 0.327 | D02XJY | 0.254 | ||||
ENC000478 | 0.300 | D06QKV | 0.250 | ||||
ENC001461 | 0.294 | D0AO5H | 0.239 | ||||
ENC000499 | 0.283 | D0G4YT | 0.231 | ||||
ENC001363 | 0.281 | D0E9CD | 0.224 | ||||
ENC000736 | 0.277 | D0Y7TS | 0.221 | ||||
ENC000349 | 0.277 | D0Q4YI | 0.217 | ||||
ENC001512 | 0.273 | D01XNB | 0.213 |